Meredith K Zappia, LCSW, LCADC in Asbury Park, NJ - Social Worker

Meredith K Zappia, LCSW, LCADC is a Social Worker based in Asbury Park, New Jersey. Meredith K Zappia is licensed to practice in New Jersey (license number 44SL06462100) and her current practice location is 705 Summerfield Ave, Asbury Park, New Jersey. She can be reached at her office (for appointments etc.) via phone at (732) 774-6886.

NPI number for Meredith K Zappia is 1821750191 and her current mailing address is 705 Summerfield Ave, Asbury Park, New Jersey. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1821750191.

Contact Information

	Meredith K Zappia, LCSW, LCADC
	705 Summerfield Ave, Asbury Park, NJ 07712-6921
	(732) 774-6886
	(732) 774-8809

Healthcare Provider's Profile

Full Name	Meredith K Zappia
Gender	Female
Speciality	Social Worker
Location	705 Summerfield Ave, Asbury Park, New Jersey
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1821750191
Provider Enumeration Date: 10/13/2021
Last Update Date: 01/10/2023

Medical Identifiers

Medical identifiers for Meredith K Zappia such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1821750191	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
101YA0400X	Counselor - Addiction (substance Use Disorder)	37LC00338100 (New Jersey)	Secondary
104100000X	Social Worker	44SL06462100 (New Jersey)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Meredith K Zappia is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Meredith K Zappia, LCSW, LCADC 705 Summerfield Ave, Asbury Park, NJ 07712-6921 Ph: (732) 774-6886	Meredith K Zappia, LCSW, LCADC 705 Summerfield Ave, Asbury Park, NJ 07712-6921 Ph: (732) 774-6886

News Archive

Three Penn labs receive NIH grant to speed translation of medical research into patient care

Three labs from the University of Pennsylvania have received $12.5 million from the National Institutes of Health (NIH) as part of its $143.8 million national grant program to challenge the scientific status quo with innovative ideas that have the potential to speed the translation of medical research into improved health for the American public.

Breast pumps could be transmitting asthma-causing bacteria in babies, finds study

Mothers across the world use breast pumps to pump put the milk that is fed to their babies. A new study has revealed that these pumps may not be safe and may be contaminated with bacteria that can cause asthma in the babies later in life. The results of this study were published in the latest issue of the journal Cell Host & Microbe.

Lexicon reports top-line results from LX2931 Phase 2a study in rheumatoid arthritis

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced top-line results from a recently completed Phase 2a study of LX2931 in patients with rheumatoid arthritis (RA). LX2931 is an orally-delivered, small molecule drug candidate that inhibits sphingosine-1-phosphate (S1P) lyase, an enzyme important for modulating the immune system by controlling S1P levels in lymphoid tissues.

Researchers design pacemaker powered by energy of heartbeats

Implantable pacemakers have without doubt altered modern medicine, saving countless lives by regulating heart rhythm. But they have one serious shortcoming: Their batteries last only five to 12 years, at which point they have to be replaced surgically.

Views on meningitis outbreak: FDA says it is working to contain risks; USA Today says regulators had 'ample warning of the potential risks'

The ongoing meningitis outbreak and its impact on patients and their families is a tragedy, and our hearts go out to the patients and their families who have suffered as a result of these events. The FDA's top priority is to fully contain the health risks associated with the outbreak as quickly as possible, and we will continue to work tirelessly to do so.

Meredith K Zappia, LCSW, LCADC - Counselor in Asbury Park, NJ